Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection — New York, 2022-Reference-Cited by-同舟云学术

Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection — New York, 2022

Published:2023-05-19 Issue:20 Volume:72 Page:559-563
ISSN:0149-2195
Container-title:MMWR. Morbidity and Mortality Weekly Report
language:
Short-container-title:MMWR Morb. Mortal. Wkly. Rep.

Author:

Rosenberg Eli S.,Dorabawila Vajeera,Hart-Malloy Rachel,Anderson Bridget J.,Miranda Wilson,O’Donnell Travis,Gonzalez Charles J.,Abrego Meaghan,DelBarba Charlotte,Tice Cori J.,McGarry Claire,Mitchell Ethan C.,Boulais Michele,Backenson Bryon,Kharfen Michael,McDonald James,Bauer Ursula E.

Publisher

Centers for Disease Control MMWR Office

Subject

Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology

Reference10 articles.

1. Phase 3 efficacy trial of Modified Vaccinia Ankara as a vaccine against smallpox.;Pittman;N Engl J Med,2019

2. Comparison of lyophilized versus liquid Modified Vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects.;Frey;Vaccine,2015

3. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.;Earl;Proc Natl Acad Sci U S A,2008

4. COVID-19 vaccine effectiveness in New York state.;Rosenberg;N Engl J Med,2022

5. Reduced risk for mpox after receipt of 1 or 2 doses of JYNNEOS vaccine compared with risk among unvaccinated persons—43 U.S. jurisdictions, July 31–October 1, 2022.;Payne;MMWR Morb Mortal Wkly Rep,2022

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: A systematic review and meta-analysis;Vaccine;2024-11

2. Effectiveness of modified vaccinia Ankara-Bavarian Nordic vaccine against mpox infection: emulation of a target trial;BMJ;2024-09-11

3. Vaccines against mpox: MVA-BN and LC16m8;Expert Review of Vaccines;2024-09

4. Real-world safety data for MVA-BN: Increased frequency of syncope following intradermal administration for immunization against mpox disease;Vaccine;2024-09

5. Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates;Cell;2024-09